Advertisement
Advertisement
default-image

The US Food and Drugs Administration (FDA) eight days ago approved of Pfizer's combination drugs in the form of nirmatrelvir and retonavir tablets for emergency use. This tablet has been given approval for mild to medium symptoms of coronavirus in adults and children of 12 years and above.

An event was organised at the Eskayef office on Thursday evening regarding the new drug. Speaking at the event, the prime minister's personal physician and medicine specialist Professor ABM Abdullah said, the drug is good news for the new year. He greeted and thanked Eskayef for introducing the drug to the market.

From the very beginning of the pandemic, Eskayef has been endeavouring to introduce effective drugs within the soonest possible time for the people. This new drug was part of that continued effort
Simeen Rahman, managing director and CEO of Eskayef Pharmaceuticals Limited
default-image

Director, Non-Communicable Disease Control, Directorate General Health Services, Md Robed Amin, joining the launching event virtually, said it is hoped that the drug will be effective against Omicron, the new variant of coronavirus.

A video message of the managing director and CEO of Eskayef Pharmaceuticals Limited, Simeen Rahman, was screened towards the end of the event. Simeen Rahman said from the very beginning of the pandemic, Eskayef has been endeavouring to introduce effective drugs within the soonest possible time for the people. This new drug was part of that continued effort.

Read more from Bangladesh
Post Comment
Advertisement
Advertisement